8/13/24 16:13 | 8/12/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | M.d | 72 | 13.85 | 0 | 5 | 9 | 60 | D | | | | | | | | | | | | | | |
3/19/24 16:03 | 3/18/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -564 | 56.90 | 0 | -10 | -15 | 55 | D | | | | | | | | | | | | | | |
2/13/24 16:38 | 2/12/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -40 | 67.77 | 0 | -1 | -1 | 65 | D | | | | | | | | | | | | | | |
1/31/24 16:18 | 1/29/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -24 | 64.14 | 0 | 0 | -1 | 65 | D | | | | | | | | | | | | | | |
1/23/24 18:01 | 1/22/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -90 | 65.00 | 0 | -1 | -2 | 66 | D | | | | | | | | | | | | | | |
1/17/24 16:41 | 1/16/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S.d | -109 | 66.81 | 0 | -2 | -2 | 67 | D | | | | | | | | | | | | | | |
10/24/23 16:18 | 10/23/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -6 | 46.04 | 0 | 0 | 0 | 52 | D | | | | | | | | | | | | | | |
8/18/22 16:02 | 8/17/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 78 | 15.52 | 0 | 5 | 21 | 29 | D | | | | | | | | | | | | | | |
8/18/22 16:02 | 8/17/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -348 | 69.50 | 0 | -5 | -15 | 29 | D | | | | | | | | | | | | | | |
8/12/22 16:58 | 8/11/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 78 | 15.52 | 0 | 5 | 21 | 29 | D | | | | | | | | | | | | | | |
8/12/22 16:58 | 8/11/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -335 | 67.00 | 0 | -5 | -15 | 29 | D | | | | | | | | | | | | | | |
8/8/22 16:02 | 8/4/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 155 | 15.52 | 0 | 10 | 52 | 29 | D | | | | | | | | | | | | | | |
8/8/22 16:02 | 8/4/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -608 | 60.75 | 0 | -10 | -25 | 29 | D | | | | | | | | | | | | | | |
7/28/22 16:03 | 7/27/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 78 | 15.52 | 0 | 5 | 21 | 29 | D | | | | | | | | | | | | | | |
7/28/22 16:03 | 7/27/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -285 | 57.00 | 0 | -5 | -15 | 29 | D | | | | | | | | | | | | | | |
7/21/22 16:31 | 7/19/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 78 | 15.52 | 0 | 5 | 21 | 29 | D | | | | | | | | | | | | | | |
7/21/22 16:31 | 7/19/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -282 | 56.42 | 0 | -5 | -15 | 29 | D | | | | | | | | | | | | | | |
6/21/22 16:11 | 6/16/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 139 | 13.85 | 0 | 10 | 52 | 29 | D | | | | | | | | | | | | | | |
6/21/22 16:11 | 6/16/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -418 | 41.79 | 0 | -10 | -25 | 29 | D | | | | | | | | | | | | | | |
4/22/22 17:35 | 4/20/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 109 | 15.52 | 0 | 7 | 33 | 28 | D | | | | | | | | | | | | | | |
4/22/22 17:35 | 4/20/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -368 | 52.53 | 0 | -7 | -20 | 28 | D | | | | | | | | | | | | | | |
7/22/21 16:24 | 7/21/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 16 | 15.52 | 0 | 1 | 12 | 9 | D | | | | | | | | | | | | | | |
7/22/21 16:24 | 7/21/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -65 | 65.00 | 0 | -1 | -10 | 9 | D | | | | | | | | | | | | | | |
7/16/21 18:40 | 7/15/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 16 | 15.52 | 0 | 1 | 12 | 9 | D | | | | | | | | | | | | | | |
7/16/21 18:40 | 7/15/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -62 | 62.30 | 0 | -1 | -10 | 9 | D | | | | | | | | | | | | | | |
6/16/21 16:32 | 6/15/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 62 | 15.52 | 0 | 4 | 73 | 9 | D | | | | | | | | | | | | | | |
6/16/21 16:32 | 6/15/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -260 | 64.96 | 0 | -4 | -30 | 9 | D | | | | | | | | | | | | | | |
5/19/21 16:04 | 5/18/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | M.d | 31 | 15.52 | 0 | 2 | 27 | 9 | D | | | | | | | | | | | | | | |
5/19/21 16:04 | 5/18/21 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -110 | 55.00 | 0 | -2 | -17 | 9 | D | | | | | | | | | | | | | | |